Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis
- 1 October 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Hematology
- Vol. 108 (4), 447-451
- https://doi.org/10.1007/s12185-018-2461-z
Abstract
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare subtype of myeloid neoplasm. Clonal evolution in the development of BPDCN remains to be elucidated. In the present study, we examined clonal evolution in a case of BPDCN by analyzing the distribution of gene mutations in tumor cells and non-tumor blood cells. The p.D1129fs and p.K1005fs TET2 mutations, p.P95H SRSF2 mutation, and p.L287fs NPM1 mutation were identified in a skin tumor at diagnosis and peripheral blood mononuclear cells at relapse. Notably, the p.D1129fs TET2 and p.L287fs NPM1 mutations were observed only in tumor cells, while the p.K1005fs TET2 and p.P95H SRSF2 mutations were found in both tumor cells and non-tumor blood cells. Recent genetic studies have suggested that some blood cancers may originate from clonal hematopoiesis, harboring somatic mutations. In the present case, the data suggest that BPDCN originated from clonal hematopoiesis with the p.K1005fs TET2 and p.P95H SRSF2 mutations via acquisition of the additional p.D1129fs TET2 and p.L287fs NPM1 mutations.Keywords
This publication has 18 references indexed in Scilit:
- Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasmLeukemia, 2017
- Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasmsBlood, 2016
- KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasmCancer Genetics, 2015
- Identification of SUPT3H as a novel 8q24/MYC partner in blastic plasmacytoid dendritic cell neoplasm with t(6;8)(p21;q24) translocationBlood Cancer Journal, 2015
- Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasmOncotarget, 2014
- TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrowAmerican Journal of Hematology, 2013
- The first case of blastic plasmacytoid dendritic cell neoplasm with MLL-ENL rearrangementLeukemia Research, 2012
- Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletionBlood, 2011
- TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasmBritish Journal of Haematology, 2011
- Alterations of the Cell-Cycle Inhibitors p27KIP1 and p16INK4a Are Frequent in Blastic Plasmacytoid Dendritic Cell NeoplasmsJournal of Investigative Dermatology, 2010